Humacyte is selling for under 1.77 as of the 19th of June 2024; that is -6.35 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.77. Humacyte has more than 69 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Humacyte are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of March 2024 and ending today, the 19th of June 2024. Click here to learn more.
Humacyte cannot be verified against its exchange. It appears that Humacyte is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Humacyte (HUMAW) is traded on NASDAQ Exchange in USA. It is located in 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 and employs 183 people. Humacyte is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Humacyte generates negative cash flow from operations
Check Humacyte Probability Of Bankruptcy
Humacyte Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Humacyte market risk premium is the additional return an investor will receive from holding Humacyte long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Humacyte. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Humacyte's alpha and beta are two of the key measurements used to evaluate Humacyte's performance over the market, the standard measures of volatility play an important role as well.
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.